Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

about

DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.

P2860

Q37736567-26CF7A51-60A1-4A59-ACDC-7EA1223C9FED

P2860

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

Item

http://www.wikidata.org/entity/Q38744400

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

@en

type

Item

label

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

@en

prefLabel

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

@en

P1476

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

@en

P2093

Chong-Xian Pan

http://www.w3.org/2001/XMLSchema#string

George D Cimino

http://www.w3.org/2001/XMLSchema#string

Hongyong Zhang

http://www.w3.org/2001/XMLSchema#string

Kenneth Turteltaub

http://www.w3.org/2001/XMLSchema#string

Maike Zimmermann

http://www.w3.org/2001/XMLSchema#string

Michael A Malfatti

http://www.w3.org/2001/XMLSchema#string

Paul T Henderson

http://www.w3.org/2001/XMLSchema#string

Ralph de Vere White

http://www.w3.org/2001/XMLSchema#string

Sisi Wang

http://www.w3.org/2001/XMLSchema#string

Tiffany M Scharadin

http://www.w3.org/2001/XMLSchema#string

P2860

Current perspectives in bladder cancer management

Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer

Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells

Accelerator mass spectrometry for biomedical research.

Cellular pharmacology of gemcitabine.

Recent advances in the diagnosis and treatment of bladder cancer.

A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance.

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.

Pharmacogenomics in bladder cancer.

P304

1843-1848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.CHEMRESTOX.6B00247

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27657672

http://www.w3.org/2001/XMLSchema#string

P932

5385140

http://www.w3.org/2001/XMLSchema#string

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

about

P2860

P2860

Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932